ACET_OUT_1 [2025-03-24 11:09:37 -0400] 2125 Bytes | 618 tokens | Cum: 618 tkns (7.72% of 8k)
==========================================================================

Booyah, my friends! It's already 11:09:35 AM on Mon Mar 24, 2025 -0400, and I've got my eyes locked on Adicet Bio (ACET), pushing up to 0.9349 from 0.7661. Are we in for a serious bull run, or is this just hype? I've pulled the data—let's break it down!

Here's the first list of news for Adicet Bio:

C1 - Mar-23-25 08:43AM - Adicet Bio (ACET): Among the Penny Stocks With Huge Upside Potential According to Analysts
C2 - Mar-06-25 04:01PM - Adicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress
C3 - Mar-03-25 07:00AM - Adicet Announces Poster Presentations Highlighting ADI-270 Data at the Society for Immunotherapy of Cancer (SITC) 2025 Spring Scientific Meeting
C4 - Feb-27-25 08:36AM - Adicet Bio shares rise on FDA Fast Track Designation for ADI-001
C5 - Feb-27-25 08:36AM 07:00AM - Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Systemic Sclerosis (SSc)
C6 - Feb-05-25 07:10AM - Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Refractory Systemic Lupus Erythematosus (SLE) with Extrarenal Involvement
C7 - Jan-31-25 06:06PM - Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
C8 - Jan-29-25 07:00AM - Adicet Bio to Participate in a Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Adicet Bio (ACET)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

ACET_OUT_3 [2025-03-24 11:09:42 -0400] 1038 Bytes | 277 tokens | Cum: 897 tkns (11.21% of 8k)
==========================================================================

Showing C1 (chunk 1 of 9): C1:
**Adicet Bio (ACET): Among the Penny Stocks With Huge Upside Potential According to Analysts**
Date: Mar-23-25 08:43AM
Source: (InsiderMonkey)
URL: https://www.insidermonkey.com/blog/adicet-bio-acet-among-the-penny-stocks-with-huge-upside-potential-according-to-analysts-1489560

Our #1 AI Stock Pick is on asteep discount- 29$ instead of 99$!Click hereto access exclusive investment research and ad free browsing!

Our #1 AI Stock Pick is on asteep discount- 29$ instead of 99$!Click hereto access exclusive research!

We recently published a list of10 Penny Stocks With Huge Upside Potential According To Analysts. In this article, we are going to take a look at where Adicet Bio, Inc. (NASDAQ:ACET) stands against other penny stocks with the biggest upside potential.

Penny stocks trade below $5 and attract investors looking for high returns with a small initial investment. These stocks are

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

ACET_OUT_5 [2025-03-24 11:09:44 -0400] 887 Bytes | 273 tokens | Cum: 1219 tkns (15.24% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-23T12:43:57Z - Adicet Bio (ACET): Among the Penny Stocks With Huge Upside Potential According to Analysts...
A2 - 2025-03-22T14:11:18Z - Adicet Bio (NASDAQ:ACET) Receives "Buy" Rating from Guggenheim...
A3 - 2025-03-21T15:00:38Z - ACET Stock Dips to 52-Week Low at $0.74 Amid Market Challenges By Investing.com...
A4 - 2025-03-17T10:31:01Z - North American Morning Briefing : Stock Futures -2-...
A5 - 2025-03-11T07:17:03Z - Adicet Bio (ACET) Projected to Post Quarterly Earnings on Tuesday...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

ACET_OUT_7 [2025-03-24 11:09:45 -0400] 1038 Bytes | 258 tokens | Cum: 1479 tkns (18.49% of 8k)
==========================================================================

Showing A1 (chunk 1 of 4): A1:
**Adicet Bio (ACET): Among the Penny Stocks With Huge Upside Potential According to Analysts**Date: 2025-03-23Source: {'uri': 'ca.finance.yahoo.com', 'dataType': 'news', 'title': 'Yahoo! Finance'}URL: https://ca.finance.yahoo.com/news/adicet-bio-acet-among-penny-124357821.htmlWe recently published a list of 10 Penny Stocks With Huge Upside Potential According To Analysts. In this article, we are going to take a look at where Adicet Bio, Inc. (NASDAQ:ACET) stands against other penny stocks with the biggest upside potential.

Penny stocks trade below $5 and attract investors looking for high returns with a small initial investment. These stocks are often associated with small-cap and mid-cap companies, which have traditionally outperformed large-cap stocks due to their growth potential and higher risk. However, in recent years, these smaller firms have struggled to keep pace, as large-

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

ACET_OUT_9 [2025-03-24 11:09:47 -0400] 816 Bytes | 291 tokens | Cum: 1772 tkns (22.15% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-12-26T15:52:00Z - ACET Founder Acme Proposes Using Bitcoin Integration to Transform Thailand Economy
B2 - 2024-04-04T12:38:00Z - Why Adicet Bio (ACET) Stock Might be a Great Pick
B3 - 2024-04-03T15:26:00Z - Evaxion (EVAX) Up on Upbeat Preclinical S. Aureus Vaccine Data
B4 - 2024-04-01T13:40:10Z - Is Adicet Bio (ACET) Outperforming Other Medical Stocks This Year?
B5 - 2024-03-28T15:01:00Z - Apogee (APGE) Stock Rallies 95.6% in a Month: Here's Why
B6 - 2024-03-28T11:06:00Z - Akebia (AKBA) Up as Vafseo Gets FDA Nod for Anemia Due to CKD

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

ACET_OUT_11 [2025-03-24 11:09:51 -0400] 741 Bytes | 182 tokens | Cum: 1956 tkns (24.45% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**ACET Founder Acme Proposes Using Bitcoin Integration to Transform Thailand Economy**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2024/12/26/3001982/0/en/ACET-Founder-Acme-Proposes-Using-Bitcoin-Integration-to-Transform-Thailand-Economy.htmlAcme Worawat, founder of the ACET (ACT) digital currency, has proposed integrating Bitcoin into Thailand's economic framework, including utilizing it as part of the country's reserve fund. The initiative aims to position Thailand as a global leader in Blockchain technology and attract global crypto investments.

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

ACET_OUT_13 [2025-03-24 11:09:52 -0400] 794 Bytes | 206 tokens | Cum: 2216 tkns (27.70% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-03-06 10-K Item 7. Mgts Discussion and Analysis of Fin Cond and Results of Oper.

You should read the following discussion and analysis of our financial condition and results of operations together with our CONS financial statements and related notes includ...

S2 - 2025-03-06 8-K Item 2.02 Results of Oper and Fin Cond.

On March 6, 2025, Adicet Bio, Inc. announced its financial results for the quarter and year ended December 31, 2024. A copy of the press release is being furnished as Exhibit 99.1 to this Curr Report on Form 8-K.

The...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

ACET_OUT_15 [2025-03-24 11:09:54 -0400] 1038 Bytes | 204 tokens | Cum: 2422 tkns (30.28% of 8k)
==========================================================================

Showing S1 (chunk 1 of 6): S1:
Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations.

You should read the following discussion and analysis of our financial condition and results of operations together with our consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K. This discussion and other parts of this Annual Report on Form 10-K contain forward-looking statements that involve risks and uncertainties, such as our plans, objectives, expectations, intentions and beliefs. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified below and those discussed in the section entitled Risk Factors included elsewhere in this Annual Report on Form 10-K.

Overview

We are a clinical

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

ACET_OUT_17 [2025-03-24 11:10:09 -0400] 6081 Bytes | 1721 tokens | Cum: 4145 tkns (51.81% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+---------------------+---------------------+----------------------+-------------------------+-------------------------+----------------------+
| Volume: 818,644 | SMA50: 1.97% | Market Cap: 74.88M | Option/Short: Yes / Yes | Sales past 5Y: 342.10% | Sales Surprise: - |
+---------------------+---------------------+----------------------+-------------------------+-------------------------+----------------------+
| Avg Volume: 793.34K | SMA200: -23.80% | Shs Outstand: 82.57M | Short Float: 4.81% | Employees: 152 | EPS Surprise: 10.29% |
+---------------------+---------------------+----------------------+-------------------------+-------------------------+----------------------+
| Rel Volume: 4.05 | Perf Week: 16.48% | Shs Float: 65.36M | Short Ratio: 3.96 | Debt/Eq: 0.09 | P/E: - |
+---------------------+---------------------+----------------------+-------------------------+-------------------------+----------------------+
| RSI (14): 57.69 | Perf Month: -6.98% | Inst Own: 50.68% | Short Interest: 3.14M | Sales Y/Y TTM: -100.00% | Earnings: Mar 06 AMC |
+---------------------+---------------------+----------------------+-------------------------+-------------------------+----------------------+
| ATR (14): 0.06 | Perf Quarter: 1.13% | Insider Own: 20.96% | Beta: 2.00 | ROE: -65.65% | |
+---------------------+---------------------+----------------------+-------------------------+-------------------------+----------------------+
| SMA20: 9.89% | Index: - | Insider Trans: 0.00% | Sales Q/Q: - | ROI: -58.35% | |
+---------------------+---------------------+----------------------+-------------------------+-------------------------+----------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

Inside Trans: Adicet Bio, Inc. (ACET) by Harvey Brian Nicholas (Chief Financial Officer) on 2025-01-31
- Stock Option (Right to Buy): 324040 shares at $0 (D)

Inside Trans: Adicet Bio, Inc. (ACET) by Maltzman Julia D. (Chief Medical Officer) on 2025-01-31
- Stock Option (Right to Buy): 750000 shares at $0 (D)

Inside Trans: Adicet Bio, Inc. (ACET) by Healey Don (Chief Technology Officer) on 2025-01-31
- Stock Option (Right to Buy): 275000 shares at $0 (D)

Inside Trans: Adicet Bio, Inc. (ACET) by Schor Chen (President & CEO) on 2025-01-31
- Stock Option (Right to Buy): 763829 shares at $0 (D)

Inside Trans: Adicet Bio, Inc. (ACET) by Aftab Blake (Chief Scientific Officer) on 2025-01-31
- Stock Option (Right to Buy): 275000 shares at $0 (D)

Inside Trans: Adicet Bio, Inc. (ACET) by Harvey Brian Nicholas (Chief Financial Officer) on 2025-01-24
- Common Stock: 8752 shares at $0.9218 (D) Footnote: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person.

Inside Trans: Adicet Bio, Inc. (ACET) by Aftab Blake (Chief Scientific Officer) on 2025-01-24
- Common Stock: 6270 shares at $0.9218 (D) Footnote: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person.

Inside Trans: Adicet Bio, Inc. (ACET) by Healey Don (Chief Technology Officer) on 2025-01-24
- Common Stock: 8560 shares at $0.9218 (D) Footnote: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person.

[Company Financial Summary]
[Company Details]
Name: Adicet Bio, Inc. Common Stock
Market Cap: 75930324.225
Shares Outstanding: 82685750
Sector: PHARMACEUTICAL PREPARATIONS

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -117122000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 0.9243
Average Volume: 401643.57
30-Day High: 0.9246
30-Day Low: 0.763

[Detailed Financials: TTM 2024]
- Total Assets: $220,219,000.0
- Total Liabilities: $33,610,000.0
- Total Equity: $186,609,000.0
- Current Assets: $180,136,000.0
- Current Liabilities: $19,392,000.0

[Income Statement: TTM 2024]
- Revenue: $0.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -1.33

[Cash Flow Statement: TTM 2024]
- Net Cash Flow: $-100,313,000.0

[Detailed Financials: FY 2024]
- Total Assets: $220,219,000.0
- Total Liabilities: $33,610,000.0
- Total Equity: $186,609,000.0
- Current Assets: $180,136,000.0
- Current Liabilities: $19,392,000.0

[Income Statement: FY 2024]
- Revenue: $0.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -1.33

[Cash Flow Statement: FY 2024]
- Net Cash Flow: $-100,313,000.0
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

ACET_OUT_19 [2025-03-24 11:10:15 -0400] 676 Bytes | 167 tokens | Cum: 4587 tkns (57.34% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

ACET_IN_21 [2025-03-24 11:10:15 -0400] 126 Bytes | 29 tokens | Cum: 4690 tkns (58.63% of 8k)
==========================================================================

====================================
[2025-03-24 08:10:15] # Analysis Completed
Elapsed Time: 40.40 seconds